Differential class III antiarrhythmic effects of ambasilide and dofetilide at different extracellular potassium and pacing frequencies

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 2, 1996, Pages 314-320

  Gjini, Viktor ^a,c   Korth, Michael ^b   Schreieck, Jürgen ^a   Weyerbrock, Sonja ^a   Schömig, Albert ^a   Schmitt, Claus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

Author keywords

Action potential duration; Ambasilide; Dofetilide; Extracellular potassium; Frequency dependent effect

Indexed keywords

AMBASILIDE; ANTIARRHYTHMIC AGENT; DOFETILIDE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FREQUENCY ANALYSIS; GUINEA PIG; HEART ARRHYTHMIA; HEART PACING; HEART PAPILLARY MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA;

ACTION POTENTIALS; AMINOBENZOIC ACIDS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CARDIAC PACING, ARTIFICIAL; EXTRACELLULAR SPACE; FEMALE; GUINEA PIGS; HEART; HEART RATE; MALE; MEMBRANE POTENTIALS; PHENETHYLAMINES; POTASSIUM; SULFONAMIDES;

EID: 0029779365     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199608000-00019     Document Type: Article

References (54)

1. Singh BN. Whither antiarrhythmic drugs? In: Singh BN, Wellens HJJ, Hiraoka M, eds. Electropharmacological control of cardiac arrhythmias. Mount Kisco, NY: Futura, 1994:413-33.
2. Katritsis D, Camm AJ. New class III antiarrhythmic drugs. Ear Heart J 1993;14H93-9.
3. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992;262:809-17.
4. Hondeghem L, Snyders D. Class III antiarrhythmic agents have a lot of potential but a long way to go. Circulation 1990;81:686-90.
5. Schmitt C, Brachmann J, Karen M, et al. Reverse use-dependence effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle. Am J Cardiol 1991;68:1183-87.
6. + current by dofetilide. Circ Res 1993;72:75-83.
7. Sager P, Uppal P, Follmer C, Antinisiaris M, Pruitt C, Singh B. Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation 1993;88:1063-71.
8. Zhang Z, Follmer C, Sarma J, Chen F, Singh B. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current, J Pharmacol Exp Ther 1992;263: 40-8.
9. Coronel R. Heterogeneity in extracellular potassium concentration during early myocardial ischemia and reperfusion: implications for arrhythmogenesis. Cardiovasc Res 1994;28: 770-7.
10. Cobbe S, Manley S, Alexopoulos D. Interaction of the effects of hypoxia, substrate depletion, acidosis and hyper-kalemia on the class III antiarrhythmic properties of sotalol. Cardiovasc Res 1985;19:668-73,
11. Cobbe S, Manley S, Alexopoulos D. The influence of acute myocardial ischemia on the class III antiarrhythmic action of sotalol. Cardiovasc Res 1985;19:661-7.
12. Moro C, Romero J, Corres-Peiretii M. Amiodarone and hypokalemia, a dangerous combination. Int J Cardiol 1986;13: 365-8.
13. Villemaire C, Nattel S. Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis. Circulation 1994;89: 2870-8.
14. Cleland J, Dargie H, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J 1987;58: 572-82.
15. + channels in guinea-pig heart cells. J Physiol 1991;435:83-99.
16. + channels in cardiovascular medicine. Springer-Verlag, 1993:41-67.
17. Firek L, Giles W. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res 1995;30: 31-8.
18. Kr potassium channel. Cell 1995;81:299-307.
19. + currents. Pflugers Arch 1992;420:180-6.
20. Boyet M, Coray A, McGuian J. Cow ventricular muscle. I. The effect of the extracellular potassium concentration on the current-voltage relationship. II. Evidence for a time-dependent outward current. Pflugers Arch 1980;389:37-44.
21. max, threshold potential, and membrane input resistance in guinea pig and cat ventricular myocardium. Circ Res 1979;44:800-14.
22. Takanaka C, Sarma J, Singh B. Electrophysiologic effects of ambasilide, a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle. J Cardiovasc Pharmacol 1992;19:290-8.
23. Kr blockers dofetilide, D-SO-talol, E-4031, and MK-499, J Cardiovasc Pharmacol 1994; 24:199-208.
24. Honerjäger P. The contribution of Na channel block to the negative inotropic effect of antiarrhythmic drugs. Basic Res Cardiol 1986;81 (suppl 1):33-7.
25. Coraboeuf E, Deroubaix E, Coulombe A. Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. Am J Physiol 1979;236:H561-7.
26. Sakakibara Y, Furukawa T, Singer D, et al. Sodium current in isolated human ventricular myocytes. Am J Physiol 1993; 265:H1301-9.
27. Sager P, Nademanee K, Antimisiaris M, et al. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans. Circulation 1993;88:1072-82.
28. Follmer C, Zhang Z, Singh B. Ambasilide: a novel class III compound with a differential effect on repolarization in ventricular muscle and Purkinje fibers. In: Singh BN, Wellens HJJ, Hiraoka M, eds. Electropharmacological control of cardiac arrhythmias. Mount Kisco, NY: Futura, 1994: 611-27.
29. Feng J, Wang Z, Li G, Nattel S. Effects of class III drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes. Circulation 1995;92 (suppl I): 158.
30. Koidl B, Flaschberger P, Schaffer P, et al. Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol 1996;353:226-32.
31. + channel. Proc Natl Acad Sci USA 1992;89:2466-70.
32. + in single cardiac Purkinje cells. Am J Physiol 1989;257: C1086-92.
33. + sensitivity. Pflugers Arch 1989;414(suppl):S88-92.
34. Yang T, Tande P, Lathrop D, Refsum H. Effect of extracellular potassium on the electrophysiological effects of UK-68,798, a class III antiarrhythmic agent, in guinea pig papillary muscle. J Mol Cell Cardiol 1991;23(suppl):S111.
35. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96: 195-215.
36. + current in the ventricular myocytes of the guinea pig type. Theoretical formulation and their role in repolarization. Circ Res 1995;77:140-52.
37. + channels by intracellular factors. In: Vereecke J, van Bogaert P, Verdonck F, eds. Potassium channels in normal and pathological conditions. Leuven: Leuven University Press, 1995:103-17.
38. + channels as an antiarrhythmic mechanism. In: Vereecke J, van Bogaert P, Verdonck F, eds. Potassium channels in normal and pathological conditions. Leuven, Leuven University Press, 1995:151-66.
39. Attwell D, Cohen I, Eisner D. The effects of heart rate on the action potential of guinea-pig and human ventricular muscle. J Physiol 1981;313:439-61.
40. Kunze D. Rate-dependent changes in extracellular potassium in the rabbit atrium. Circ Res 1979;41:122-7.
41. Kiehn J, Villena P, Beyer T, Brachmann J. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes. J Cardiovasc Pharmacol 1994;24:566-72.
42. Sager P. Frequency-dependent electrophysiologic effects of dofetilide in humans. Circulation 1995;92 (suppl I):774.
43. K blocking drug. UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 1990;16:401-10.
44. Gwilt M, Arrowsmith J, Blackburn K, et al. UK-68,798: A novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells, J Pharmacol Exp Ther 1991;256:318-24.
45. Sedgwick M, Rasmussen H, Cobbe S. Clinical and electrophysiological effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris. Am J Cardiol 1992;69:513-7.
46. Yuan S, Wohlfart B, Rasmussen HS, Olsson S, Blomström-Lundqvist C. Effect of dofetilide on cardiac repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle. Eur Heart J 1994;15:514-22.
47. Ohler A. Amos GJ, Wettwer E, Ravens U. Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for ''reverse use dependent" block. Naunyn Schmieddebergs Arch Pharmocol 1994;349:602-10.
48. Veldkamp MW, van Ginneken ACG, Opthof T, Bouman LN. Delayed rectifier channels in human ventricular myocytes. Circulation 1995;92:3497-504.
49. + currents in human atrial and ventricular myocytes [Abstract]. Circulation 1995;92:I-575.
50. Schreieck J, Korth M, Meisner H, Weyerbrock S, Schmitt C, Schomig A. Rate-independent prolongation of transmembrane action potential by ambasilide in failing human myocardium [Abstract]. J Am Coll Cardiol 1996;27:374A.
51. o and TQ potential and the inducibility of ventricular fibrillation during acute regional ischemia in the isolated perfused porcine heart. Circulation 1995;92:120-9.
52. Pelleg A, Mitamura H, Price R, et al. Extracellular potassium ion dynamics and ventricular arrhythmias in the canine heart. J Am Coll Cardiol 1989:13:941-50.
53. Winslow E, Marshall R, Hope F. Effects of diet-induced hypokalemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or dysopiramide in the anaesthetised rat. J Cardiovasc Pharmacol 1987;9:267-75.
54. Winslow E, Marshall R, Campbell J, Muir A. Effects of diet-induced hypokalemia on the efficacy of the antiarrhythmic drugs against ventricular arrhythmias evoked by coronary ligation in the anaesthetised rat. J Cardiovasc Pharmacol 1987;9:256-66.